Evidence map›Paper›PMID 37321451›Full record

ArticleThe Journal of biological chemistry2023

The distinct initiation sites and processing activities of TTLL4 and TTLL7 in glutamylation of brain tubulin.

Xinyue Zhang, Xiangxiao Li, Wei Chen, Yujuan Wang, Lei Diao, Yan Gao, Heyi Wang, Lan Bao, Xin Liang, Hui-Yuan Wu

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xinyue ZhangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Xiangxiao LiSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Wei ChenIDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.
Yujuan WangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Lei DiaoState Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Yan GaoSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Heyi WangSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China.
Lan BaoState Key Laboratory of Cell Biology, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, Shanghai, China.
Xin LiangIDG/McGovern Institute for Brain Research, School of Life Sciences, Tsinghua University, Beijing, China.
Hui-Yuan WuSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin, China. Electronic address: huiyuan.wu@tju.edu.cn.
Chinese Academy of Sciences · CNChinese Institute for Brain Research · CNTianjin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mammalian brain tubulins undergo a reversible posttranslational modification-polyglutamylation-which attaches a secondary polyglutamate chain to the primary sequence of proteins. Loss of its erasers can disrupt polyglutamylation homeostasis and cause neurodegeneration. Tubulin tyrosine ligase like 4 (TTLL4) and TTLL7 were known to modify tubulins, both with preference for the β-isoform, but differently contribute to neurodegeneration. However, differences in their biochemical properties and functions remain largely unknown. Here, using an antibody-based method, we characterized the properties of a purified recombinant TTLL4 and confirmed its sole role as an initiator, unlike TTLL7, which both initiates and elongates the side chains. Unexpectedly, TTLL4 produced stronger glutamylation immunosignals for α-isoform than β-isoform in brain tubulins. Contrarily, the recombinant TTLL7 raised comparable glutamylation immunoreactivity for two isoforms. Given the site selectivity of the glutamylation antibody, we analyzed modification sites of two enzymes. Tandem mass spectrometry analysis revealed their incompatible site selectivity on synthetic peptides mimicking carboxyl termini of α1- and β2-tubulins and a recombinant tubulin. Particularly, in the recombinant α1A-tubulin, a novel region was found glutamylated by TTLL4 and TTLL7, that again at distinct sites. These results pinpoint different site specificities between two enzymes. Moreover, TTLL7 exhibits less efficiency to elongate microtubules premodified by TTLL4, suggesting possible regulation of TTLL7 elongation activity by TTLL4-initiated sites. Finally, we showed that kinesin behaves differentially on microtubules modified by two enzymes. This study underpins the different reactivity, site selectivity, and function of TTLL4 and TTLL7 on brain tubulins and sheds light on their distinct role in vivo.

Indexed as

MicrotubulesPeptide SynthasesTubulinAnimalsBrainPolyglutamic AcidProtein IsoformsProtein Processing, Post-TranslationalPeptide SynthasesPolyglutamic AcidProtein IsoformsTubulintubulin polyglutamylasebrain developmentenzyme characterizationpolyglutamylationTTLL4TTLL7tubulin

Identifiers

PMID37321451
PMCPMC10404701
OpenAlexW4380786824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.